Literature DB >> 2160575

Transcriptional regulation of the albumin gene in cultured rat hepatocytes. Role of basement-membrane matrix.

D M Bissell1, J M Caron, L E Babiss, J M Friedman.   

Abstract

The expression of tissue-specific functions by hepatocytes in primary culture is enhanced in the presence of an extracellular matrix. A basement membrane-like substratum, derived from the Engelbreth-Holm-Swarm mouse sarcoma (EHS) and termed EHS gel, supports synthesis and secretion of albumin for at least three weeks, in contrast to a conventional substratum (plastic or collagen-coated plastic), on which cells rapidly lose this function. The presence of an EHS matrix (as a substratum or added to the medium as a dilute gel) supports transcriptional activity at 30 to 35% and specific mRNA at 70 to 80% of initial values after five days of culture, at a time when transcription in cells plated in conventional culture is undetectable. For examining the cis elements required for transcriptional regulation by EHS matrix, we are utilizing recombinant adenoviruses to introduce DNA into hepatocytes, as an alternative to transfection of DNA fragments. Initial studies are presented, in which hepatocytes are cultured on either collagen-coated plastic or on EHS gel. At various times after plating, the cultures are infected with an adenovirus containing the proximal 5' regulatory region (to -441 base-pair) of the albumin gene. The results indicate no effect of EHS gel on this proximal promoter region, implying that matrix-responsive element(s) lie further upstream, possibly within the previously described enhancer at about -10,000 base-pairs.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2160575

Source DB:  PubMed          Journal:  Mol Biol Med        ISSN: 0735-1313


  24 in total

Review 1.  Is liver fibrosis reversible?

Authors:  R C Benyon; J P Iredale
Journal:  Gut       Date:  2000-04       Impact factor: 23.059

Review 2.  Structural cues from the tissue microenvironment are essential determinants of the human mammary epithelial cell phenotype.

Authors:  K L Schmeichel; V M Weaver; M J Bissell
Journal:  J Mammary Gland Biol Neoplasia       Date:  1998-04       Impact factor: 2.673

3.  Transplantation of primary and reversibly immortalized human liver cells and other gene therapies in acute liver failure and decompensated chronic liver disease.

Authors:  Stephen M Riordan; Roger Williams
Journal:  World J Gastroenterol       Date:  2000-10       Impact factor: 5.742

4.  An extracellular matrix response element in the promoter of the LpS1 genes of the sea urchin Lytechinus pictus.

Authors:  C A Seid; R K Ramachandran; J M George; V Govindarajan; M F González-Rimbau; C N Flytzanis; C R Tomlinson
Journal:  Nucleic Acids Res       Date:  1997-08-01       Impact factor: 16.971

5.  Gene expression profiling of extracellular matrix as an effector of human hepatocyte phenotype in primary cell culture.

Authors:  Jeanine L Page; Mary C Johnson; Katy M Olsavsky; Steven C Strom; Helmut Zarbl; Curtis J Omiecinski
Journal:  Toxicol Sci       Date:  2007-02-27       Impact factor: 4.849

6.  Extended primary culture of human hepatocytes in a collagen gel sandwich system.

Authors:  Y Kono; S Yang; E A Roberts
Journal:  In Vitro Cell Dev Biol Anim       Date:  1997-06       Impact factor: 2.416

7.  The extracellular matrix coordinately modulates liver transcription factors and hepatocyte morphology.

Authors:  C M DiPersio; D A Jackson; K S Zaret
Journal:  Mol Cell Biol       Date:  1991-09       Impact factor: 4.272

8.  Advancements in in vitro hepatic models: application for drug screening and therapeutics.

Authors:  Apeksha Damania; Era Jain; Ashok Kumar
Journal:  Hepatol Int       Date:  2013-12-05       Impact factor: 6.047

9.  Effect of Tissue-Culture Substratum and Extracellular Matrix Overlay on Liver-Selective and Xenobiotic Inducible Gene Expression in Primary Rat Hepatocytes.

Authors:  J S Sidhu; F M Farin; T J Kavanagh; C J Omiecinski
Journal:  In Vitro Toxicol       Date:  1994

Review 10.  Bioconjugation of oligonucleotides for treating liver fibrosis.

Authors:  Zhaoyang Ye; Houssam S Hajj Houssein; Ram I Mahato
Journal:  Oligonucleotides       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.